Innate Pharma S.A.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Innate Pharma S.A.'s past years’ income statements indicate that its last revenue has increased compared to the previous period by 5% to $51,901,000. The net income raised on -$7,570,000 and profit margin reached -15%. Total operating expenses were $64,570,000.
Profit Margin
| 2014 | 907K | -19.64M | -2166.15% |
|---|---|---|---|
| 2015 | 17.90M | -6.70M | -37.45% |
| 2016 | 56.16M | 12.64M | 22.51% |
| 2017 | 32.63M | -48.38M | -148.28% |
| 2018 | 79.89M | 3.04M | 3.82% |
| 2019 | 68.97M | -20.96M | -30.4% |
| 2020 | 56.83M | -70.74M | -124.48% |
| 2021 | 12.11M | -59.13M | -488.24% |
| 2022 | 49.63M | -99.10M | -199.65% |
| 2023 | 51.90M | -7.57M | -14.59% |
IPHA Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 51.90M | 49.63M | 12.11M | 56.83M | 68.97M | 79.89M | 32.63M | 56.16M | 17.90M | 907K |
Cost of revenue | 56.02M | 51.66M | 47.00M | 3.04M | 45.15M | 0 | 67M | 0 | 29.90M | 12.08M |
Gross profit | -4.12M | -2.02M | -34.89M | 53.79M | 23.81M | 79.89M | -34.36M | 56.16M | -12M | -11.18M |
Operating exp. | ||||||||||
Research and development | 56.02M | 51.66M | 47.00M | 58.61M | 1.59M | 69.55M | 67M | 48.62M | 29.90M | 22.67M |
Selling and marketing | 0 | 7.96M | 9.53M | -861K | 8.84M | 1.10M | 527K | 450K | 288K | 314K |
Total operating expenses | 64.57M | 66.06M | 59.93M | 75.38M | 50.86M | 74.74M | 72.61M | 48.58M | 28.67M | 8.76M |
Operating income | -12.66M | -11.65M | -47.82M | -13.69M | -27.05M | 5.14M | -39.98M | 7.57M | -10.77M | -19.96M |
Other income (expenses), net | 5.09M | -46.32M | 2.34M | -15.52M | 6.29M | -2.14M | -8.03M | 4.68M | 4.06M | 319K |
Income before tax | -7.57M | -57.97M | -45.47M | -63.98M | -20.75M | 2.71M | -48.01M | 12.94M | -6.70M | -19.64M |
Income tax expense | 0 | 41.13M | 13.65M | 6.76M | 206K | -333K | 368K | 301K | 139K | -24K |
Net income | -7.57M | -99.10M | -59.13M | -70.74M | -20.96M | 3.04M | -48.38M | 12.64M | -6.70M | -19.64M |
Earnings per share | ||||||||||
Basic EPS | -0.09 | -1.24 | -0.74 | -0.9 | -0.31 | 0.05 | -0.89 | 0.23 | -0.13 | -0.39 |
Diluted EPS | -0.09 | -1.24 | -0.74 | -0.9 | -0.31 | 0.05 | -0.89 | 0.23 | -0.13 | -0.39 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |